Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SANDOZ INC

  • FDA Approval
  • Nov. 02, 2022, 03:41 UTC
  • 35
  • 0 comments

FDA approve SUCCINYLCHOLINE CHLORIDE

Comment Full text

JANSSEN BIOTECH

  • FDA Approval
  • Nov. 02, 2022, 03:41 UTC
  • 28
  • 0 comments

FDA approve DARATUMUMAB

Comment Full text

HIKMA

  • FDA Approval
  • Nov. 02, 2022, 03:41 UTC
  • 26
  • 0 comments

FDA approve SUCCINYLCHOLINE CHLORIDE

Comment Full text

ABBVIE

  • FDA Approval
  • Nov. 02, 2022, 03:41 UTC
  • 28
  • 0 comments

FDA approve SEVOFLURANE

Comment Full text

BAXTER HLTHCARE

  • FDA Approval
  • Nov. 02, 2022, 03:41 UTC
  • 33
  • 0 comments

FDA approve DESFLURANE

Comment Full text

BAXTER HLTHCARE

  • FDA Approval
  • Nov. 02, 2022, 03:41 UTC
  • 27
  • 0 comments

FDA approve ISOFLURANE

Comment Full text

HOSPIRA

  • FDA Approval
  • Nov. 02, 2022, 03:41 UTC
  • 32
  • 0 comments

FDA approve SUCCINYLCHOLINE CHLORIDE

Comment Full text

ASTELLAS

  • FDA Approval
  • Oct. 31, 2022, 12:10 UTC
  • 39
  • 0 comments

FDA approve ENFORTUMAB VEDOTIN-EJFV

Comment Full text

CHATTEM SANOFI

  • FDA Approval
  • Oct. 31, 2022, 11:41 UTC
  • 31
  • 0 comments

FDA approve LEVOCETIRIZINE DIHYDROCHLORIDE

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Oct. 31, 2022, 03:40 UTC
  • 20
  • 0 comments

FDA approve VIGABATRIN

Comment Full text
  • Previous
  • 948
  • 949
  • 950
  • 951
  • 952
  • Next

Search

News categories

  • Technical Exchange News(12316)
  • Event(6229)
  • SEC News(269474)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(156705)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin